Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Takayama, Shuzo ^a   Kawamoto, Ryuichi ^a,b   Kusunoki, Tomo ^a,b   Abe, Masanori ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seiyo Municipal Nomura Hospital   (Japan)

Author keywords

Cardiovascular risk factor; Carotid atherosclerosis; Gender; Metabolic syndrome; Uric acid

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; URIC ACID; BIOLOGICAL MARKER;

AGED; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RISK FACTOR; SEX DIFFERENCE; AGE; AGING; ASIAN; BLOOD; CAROTID ARTERY DISEASE; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; ETHNOLOGY; HYPERURICEMIA; INCIDENCE; JAPAN; MULTIVARIATE ANALYSIS; RISK; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS; UPREGULATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERURICEMIA; INCIDENCE; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION; URIC ACID;

EID: 84855473508     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-2     Document Type: Article

References (40)

1. National Cholesterol Education Program Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702, National Cholesterol Education Program.
2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. American Heart Association; National Heart and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
3. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112:3066-3072. 10.1161/CIRCULATIONAHA.105.539528, 16275870.
4. McNeill AM, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, Tracy RP, Savage PJ, Jackson SA. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study. J Am Geriatr Soc 2006, 54:1317-1324. 10.1111/j.1532-5415.2006.00862.x, 16970637.
5. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007, 30:8-13. 10.2337/dc06-1414, 17192325.
6. Shiwaku K, Nogi A, Kitajima K, Anuurad E, Enkhmaa B, Yamasaki M, Kim JM, Kim IS, Lee SK, Oyunsuren T, Yamane Y. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health 2005, 47:126-135. 10.1539/joh.47.126, 15824477.
7. So A, Thorens B. Uric acid transport and disease. Journal of Clinical Investigation 2010, 120:1791-1799. 10.1172/JCI42344, 2877959, 20516647.
8. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens 2001, 19:1209-1215. 10.1097/00004872-200107000-00005, 11446710.
9. Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, Elisaf MS. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J 2004, 148:635-640. 10.1016/j.ahj.2004.04.005, 15459594.
10. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 1995, 142:288-294.
11. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993, 270:354-359. 10.1001/jama.1993.03510030078038, 8315780.
12. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000, 283:2404-2410. 10.1001/jama.283.18.2404, 10815083.
13. Gagliardi AC, Miname MH, Santos RD. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis 2009, 202:11-17. 10.1016/j.atherosclerosis.2008.05.022, 18585721.
14. Sakata K, Hashimoto T, Ueshima H, Okayama A, . NIPPON DATA 80 Research Group Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged. Eur J Epidemiol 2001, 17:461-468. 10.1023/A:1013735717961, 11855580, NIPPON DATA 80 Research Group.
15. Kawamoto R, Tomita H, Oka Y, Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 2006, 45:605-614. 10.2169/internalmedicine.45.1661, 16755091.
16. Friedewald WT, Levy RI. Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
17. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arter Throm 1991, 11:1245-1249.
18. Sidhu PS, Desai SR. A simple and reproducible method for assessing intima-media thickness of the common carotid artery. Br J Radiol 1997, 70:85-89.
19. Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA, Touboul PJ. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke 2002, 23:1705-1711.
20. The examination Committee of Criteria for "Obesity Disease" in Japan Japan Society for Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002, 66:987-992. 10.1253/circj.66.987, 12419927, The examination Committee of Criteria for "Obesity Disease" in Japan.
21. Ota T, Takamura T, Hirai N, Kobayashi K. Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese. Diabetes Care 2002, 25:1252-1253. 10.2337/diacare.25.7.1252, 12087037.
22. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008, 57:845-852. 10.1016/j.metabol.2008.01.030, 2486830, 18502269.
23. Chiou WK, Wang MH, Huang DH, Chiu HT, Lee YJ, Lin JD. The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. J Epidemiol 2010, 20:219-224. 10.2188/jea.JE20090078, 20308795.
24. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?. Metabolism 2006, 55:1293-1301. 10.1016/j.metabol.2006.05.013, 16979398.
25. Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med 1998, 158:741-751. 10.1001/archinte.158.7.741, 9554680.
26. Gordon T, Kannel WB. Drinking and its relation to smoking, BP, blood lipids, and uric acid. The Framingham study. Arch Intern Med 1983, 143:1366-1374. 10.1001/archinte.1983.00350070086016, 6870410.
27. Nan H, Dong Y, Gao W, Tuomilehto J, Qiao Q. Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract 2007, 76:68-74. 10.1016/j.diabres.2006.07.022, 16963150.
28. Neogi T, Ellison RC, Hunt S, Terkeltaub R, Felson DT, Zhang Y. Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. J Rheumatol 2009, 36:378-384. 2731484, 19012359.
29. Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R. Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovascular Diabetology 2011, 10:72. Aug 2011, 10.1186/1475-2840-10-72, 3163178, 21816063.
30. Tavil Y, Kaya MG, Oktar SO, Sen N, Okyay K, Yazici HU, Cengel A. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis 2008, 197:159-163. 10.1016/j.atherosclerosis.2007.03.008, 17416371.
31. Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women. Intern Emerg Med 2007, 2:19-23. 10.1007/s11739-007-0004-3, 2780606, 17551679.
32. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005, 25:1038-1044. 10.1161/01.ATV.0000161274.87407.26, 15746438.
33. Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol 1996, 6:331-340. 10.1016/S1047-2797(96)00052-X, 8876844.
34. Pan WH, Bai CH, Chen JR, Chiu HC. Associations between carotid atherosclerosis and high factor VIII -activity, dyslipidemia, and hypertension. Stroke 1997, 28:88-94. 10.1161/01.STR.28.1.88, 8996495.
35. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ. Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2. Hypertension 2003, 41:1287-1293. 10.1161/01.HYP.0000072820.07472.3B, 12743010.
36. Baldwin WMS, Marek G, Wymer D, Pannu V, Baylis C, Johnson RJ, Sautin YY. Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome. Diabetes 2011, 60:1258-1269. 10.2337/db10-0916, 21346177.
37. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005, 25:39-42. 10.1016/j.semnephrol.2004.09.007, 15660333.
38. Sánchez-Lozada LG, Nakagawa T, Kang DH, Feig DI, Franco M, Johnson RJ, Herrera-Acosta J. Hormonal and cytokine effects of uric acid. Curr Opin Nephrol Hypertens 2006, 15:30-33. 10.1097/01.mnh.0000199010.33929.7f, 16340663.
39. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis 2000, 148:131-139. 10.1016/S0021-9150(99)00214-2, 10580179.
40. Oda E, Kawai R. Reproducibility of high-sensitivity C-reactive protein as an inflammatory component of metabolic syndrome in Japanese. Circ J 2010, 74:1488-1493. 10.1253/circj.CJ-10-0156, 20519874.